Advertisement

Index by author

March 01, 1977; Volume 5,Issue 2

A

  1. Ahmed, A E

    1. Metabolism of haloforms to carbon monoxide. I. In vitro studies.
      A E Ahmed, V L Kubic and M W Anders
      Drug Metabolism and Disposition March 1977, 5 (2) 198-204;

  2. Anders, M W

    1. Metabolism of haloforms to carbon monoxide. I. In vitro studies.
      A E Ahmed, V L Kubic and M W Anders
      Drug Metabolism and Disposition March 1977, 5 (2) 198-204;

  3. Arison, B H

    1. Urinary metabolites of amitriptyline in the dog.
      H B Hucker, A J Balletto, J Demetriades, B H Arison and A G Zacchei
      Drug Metabolism and Disposition March 1977, 5 (2) 132-142;

B

  1. Balletto, A J

    1. Urinary metabolites of amitriptyline in the dog.
      H B Hucker, A J Balletto, J Demetriades, B H Arison and A G Zacchei
      Drug Metabolism and Disposition March 1977, 5 (2) 132-142;

  2. Bellward, G D

    1. Induction of hepatic aryl hydrocarbon hydroxylase and epoxide hydrase in Wistar rats pretreated with oral methadone hydrochloride.
      G D Bellward, L S Gontovnick and M Otten
      Drug Metabolism and Disposition March 1977, 5 (2) 211-218;

  3. Birch, C G

    1. The metabolism and toxicity of halogenated carbanilides. Biliary metabolites of 3,4,4'-trichlorocarbanilide and 3-trifluoromethyl-4,4'-dichlorocarbanilide in the rat.
      A R Jeffcoat, R W Handy, M T Francis, S Willis, M E Wall, C G Birch and R A Hiles
      Drug Metabolism and Disposition March 1977, 5 (2) 157-166;

  4. Breyer, U

    1. Metabolism and disposition of trifluoperazine in the rat. I. A thin-layer chromatographic method for the measurement of trifluoperazine and its metabolites in rat tissues.
      U Breyer and G Schmalzing
      Drug Metabolism and Disposition March 1977, 5 (2) 97-103;

  5. By, A

    1. Identification of 3-O-methyl-alpha-methyldopamine as a urinary metabolite of 3,4-methylenedioxyamphetamine in dog and monkey.
      K K Midha, J K Cooper, A By and J C Ethier
      Drug Metabolism and Disposition March 1977, 5 (2) 143-148;

C

  1. Clay, K L

    1. Metabolism of pyrazole. Structure elucidation of urinary metabolites.
      K L Clay, W D Watkins and R C Murphy
      Drug Metabolism and Disposition March 1977, 5 (2) 149-156;

  2. Cooper, J K

    1. Identification of 3-O-methyl-alpha-methyldopamine as a urinary metabolite of 3,4-methylenedioxyamphetamine in dog and monkey.
      K K Midha, J K Cooper, A By and J C Ethier
      Drug Metabolism and Disposition March 1977, 5 (2) 143-148;

  3. Cunningham, R F

    1. Probenecid metabolism in vitro with rat, mouse, and human liver preparations. Studies of factors affecting the site of oxidation.
      R F Cunningham, J M Perel, Z H Israili and P G Dayton
      Drug Metabolism and Disposition March 1977, 5 (2) 205-210;

D

  1. Dayton, P G

    1. Probenecid metabolism in vitro with rat, mouse, and human liver preparations. Studies of factors affecting the site of oxidation.
      R F Cunningham, J M Perel, Z H Israili and P G Dayton
      Drug Metabolism and Disposition March 1977, 5 (2) 205-210;

  2. DeLong, A F

    1. Comparative metabolism of fenclorac in rat, dog, monkey, and man.
      A F DeLong, R D Smyth, A Polk, R K Nayak, G Martin, G H Douglas and N H Reavey-Cantiwell
      Drug Metabolism and Disposition March 1977, 5 (2) 122-131;

  3. Demetriades, J

    1. Urinary metabolites of amitriptyline in the dog.
      H B Hucker, A J Balletto, J Demetriades, B H Arison and A G Zacchei
      Drug Metabolism and Disposition March 1977, 5 (2) 132-142;

  4. Douglas, G H

    1. Comparative metabolism of fenclorac in rat, dog, monkey, and man.
      A F DeLong, R D Smyth, A Polk, R K Nayak, G Martin, G H Douglas and N H Reavey-Cantiwell
      Drug Metabolism and Disposition March 1977, 5 (2) 122-131;

E

  1. Edelson, J

    1. O-Demethylation of p-nitroanisole by Escherichia coli. Stimulation by phenobarbital.
      J Edelson and J P McMullen
      Drug Metabolism and Disposition March 1977, 5 (2) 185-190;

  2. Ethier, J C

    1. Identification of 3-O-methyl-alpha-methyldopamine as a urinary metabolite of 3,4-methylenedioxyamphetamine in dog and monkey.
      K K Midha, J K Cooper, A By and J C Ethier
      Drug Metabolism and Disposition March 1977, 5 (2) 143-148;

F

  1. Francis, M T

    1. The metabolism and toxicity of halogenated carbanilides. Biliary metabolites of 3,4,4'-trichlorocarbanilide and 3-trifluoromethyl-4,4'-dichlorocarbanilide in the rat.
      A R Jeffcoat, R W Handy, M T Francis, S Willis, M E Wall, C G Birch and R A Hiles
      Drug Metabolism and Disposition March 1977, 5 (2) 157-166;

  2. Fujimoto, J M

    1. Enhanced naloxone distribution to the brain by morphine pretreatment in mice.
      D G Lange, J M Fujimoto, S Roerig and R I Wang
      Drug Metabolism and Disposition March 1977, 5 (2) 167-173;

G

  1. Gilleran, T G

    1. Plasma levels of real and "apparent" hydralazine in man and rat.
      S B Zak, G Lukas and T G Gilleran
      Drug Metabolism and Disposition March 1977, 5 (2) 116-121;

  2. Gontovnick, L S

    1. Induction of hepatic aryl hydrocarbon hydroxylase and epoxide hydrase in Wistar rats pretreated with oral methadone hydrochloride.
      G D Bellward, L S Gontovnick and M Otten
      Drug Metabolism and Disposition March 1977, 5 (2) 211-218;

H

  1. Handy, R W

    1. The metabolism and toxicity of halogenated carbanilides. Biliary metabolites of 3,4,4'-trichlorocarbanilide and 3-trifluoromethyl-4,4'-dichlorocarbanilide in the rat.
      A R Jeffcoat, R W Handy, M T Francis, S Willis, M E Wall, C G Birch and R A Hiles
      Drug Metabolism and Disposition March 1977, 5 (2) 157-166;

  2. Hiles, R A

    1. The metabolism and toxicity of halogenated carbanilides. Biliary metabolites of 3,4,4'-trichlorocarbanilide and 3-trifluoromethyl-4,4'-dichlorocarbanilide in the rat.
      A R Jeffcoat, R W Handy, M T Francis, S Willis, M E Wall, C G Birch and R A Hiles
      Drug Metabolism and Disposition March 1977, 5 (2) 157-166;

  3. Hucker, H B

    1. Urinary metabolites of amitriptyline in the dog.
      H B Hucker, A J Balletto, J Demetriades, B H Arison and A G Zacchei
      Drug Metabolism and Disposition March 1977, 5 (2) 132-142;

I

  1. Israili, Z H

    1. Probenecid metabolism in vitro with rat, mouse, and human liver preparations. Studies of factors affecting the site of oxidation.
      R F Cunningham, J M Perel, Z H Israili and P G Dayton
      Drug Metabolism and Disposition March 1977, 5 (2) 205-210;

J

  1. Jeffcoat, A R

    1. The metabolism and toxicity of halogenated carbanilides. Biliary metabolites of 3,4,4'-trichlorocarbanilide and 3-trifluoromethyl-4,4'-dichlorocarbanilide in the rat.
      A R Jeffcoat, R W Handy, M T Francis, S Willis, M E Wall, C G Birch and R A Hiles
      Drug Metabolism and Disposition March 1977, 5 (2) 157-166;

K

  1. Kubic, V L

    1. Metabolism of haloforms to carbon monoxide. I. In vitro studies.
      A E Ahmed, V L Kubic and M W Anders
      Drug Metabolism and Disposition March 1977, 5 (2) 198-204;

L

  1. Lange, D G

    1. Enhanced naloxone distribution to the brain by morphine pretreatment in mice.
      D G Lange, J M Fujimoto, S Roerig and R I Wang
      Drug Metabolism and Disposition March 1977, 5 (2) 167-173;

  2. Less, M J

    1. Lung pH and pulmonary absorption of nonvolatile drugs in the rat.
      L S Schanker and M J Less
      Drug Metabolism and Disposition March 1977, 5 (2) 174-178;

  3. Lukas, G

    1. Plasma levels of real and "apparent" hydralazine in man and rat.
      S B Zak, G Lukas and T G Gilleran
      Drug Metabolism and Disposition March 1977, 5 (2) 116-121;

M

  1. Martin, G

    1. Comparative metabolism of fenclorac in rat, dog, monkey, and man.
      A F DeLong, R D Smyth, A Polk, R K Nayak, G Martin, G H Douglas and N H Reavey-Cantiwell
      Drug Metabolism and Disposition March 1977, 5 (2) 122-131;

  2. McMullen, J P

    1. O-Demethylation of p-nitroanisole by Escherichia coli. Stimulation by phenobarbital.
      J Edelson and J P McMullen
      Drug Metabolism and Disposition March 1977, 5 (2) 185-190;

  3. Midha, K K

    1. Identification of 3-O-methyl-alpha-methyldopamine as a urinary metabolite of 3,4-methylenedioxyamphetamine in dog and monkey.
      K K Midha, J K Cooper, A By and J C Ethier
      Drug Metabolism and Disposition March 1977, 5 (2) 143-148;

  4. Murphy, R C

    1. Metabolism of pyrazole. Structure elucidation of urinary metabolites.
      K L Clay, W D Watkins and R C Murphy
      Drug Metabolism and Disposition March 1977, 5 (2) 149-156;

N

  1. Nayak, R K

    1. Comparative metabolism of fenclorac in rat, dog, monkey, and man.
      A F DeLong, R D Smyth, A Polk, R K Nayak, G Martin, G H Douglas and N H Reavey-Cantiwell
      Drug Metabolism and Disposition March 1977, 5 (2) 122-131;

  2. Neal, R A

    1. Comparison of the metabolism of parathion by a rat liver reconstituted mixed-function oxidase enzyme system and by a system containing cumene hydroperoxide and purified rat liver cytochrome P-450.
      S Yoshihara and R A Neal
      Drug Metabolism and Disposition March 1977, 5 (2) 191-197;

O

  1. Otten, M

    1. Induction of hepatic aryl hydrocarbon hydroxylase and epoxide hydrase in Wistar rats pretreated with oral methadone hydrochloride.
      G D Bellward, L S Gontovnick and M Otten
      Drug Metabolism and Disposition March 1977, 5 (2) 211-218;

P

  1. Perel, J M

    1. Probenecid metabolism in vitro with rat, mouse, and human liver preparations. Studies of factors affecting the site of oxidation.
      R F Cunningham, J M Perel, Z H Israili and P G Dayton
      Drug Metabolism and Disposition March 1977, 5 (2) 205-210;

  2. Polk, A

    1. Comparative metabolism of fenclorac in rat, dog, monkey, and man.
      A F DeLong, R D Smyth, A Polk, R K Nayak, G Martin, G H Douglas and N H Reavey-Cantiwell
      Drug Metabolism and Disposition March 1977, 5 (2) 122-131;

R

  1. Rane, A

    1. Disposition of carbamazepine and its 10,11-epoxide metabolite in the isolated perfused rat liver.
      A Rane, D G Shand and G R Wilkinson
      Drug Metabolism and Disposition March 1977, 5 (2) 179-184;

  2. Reavey-Cantiwell, N H

    1. Comparative metabolism of fenclorac in rat, dog, monkey, and man.
      A F DeLong, R D Smyth, A Polk, R K Nayak, G Martin, G H Douglas and N H Reavey-Cantiwell
      Drug Metabolism and Disposition March 1977, 5 (2) 122-131;

  3. Roerig, S

    1. Enhanced naloxone distribution to the brain by morphine pretreatment in mice.
      D G Lange, J M Fujimoto, S Roerig and R I Wang
      Drug Metabolism and Disposition March 1977, 5 (2) 167-173;

S

  1. Schanker, L S

    1. Lung pH and pulmonary absorption of nonvolatile drugs in the rat.
      L S Schanker and M J Less
      Drug Metabolism and Disposition March 1977, 5 (2) 174-178;

  2. Schmalzing, G

    1. Metabolism and disposition of trifluoperazine in the rat. II. Kinetics after oral and intravenous administration in acutely and chronically treated animals.
      G Schmalzing
      Drug Metabolism and Disposition March 1977, 5 (2) 104-115;
    2. Metabolism and disposition of trifluoperazine in the rat. I. A thin-layer chromatographic method for the measurement of trifluoperazine and its metabolites in rat tissues.
      U Breyer and G Schmalzing
      Drug Metabolism and Disposition March 1977, 5 (2) 97-103;

  3. Shand, D G

    1. Disposition of carbamazepine and its 10,11-epoxide metabolite in the isolated perfused rat liver.
      A Rane, D G Shand and G R Wilkinson
      Drug Metabolism and Disposition March 1977, 5 (2) 179-184;

  4. Smyth, R D

    1. Comparative metabolism of fenclorac in rat, dog, monkey, and man.
      A F DeLong, R D Smyth, A Polk, R K Nayak, G Martin, G H Douglas and N H Reavey-Cantiwell
      Drug Metabolism and Disposition March 1977, 5 (2) 122-131;

W

  1. Wall, M E

    1. The metabolism and toxicity of halogenated carbanilides. Biliary metabolites of 3,4,4'-trichlorocarbanilide and 3-trifluoromethyl-4,4'-dichlorocarbanilide in the rat.
      A R Jeffcoat, R W Handy, M T Francis, S Willis, M E Wall, C G Birch and R A Hiles
      Drug Metabolism and Disposition March 1977, 5 (2) 157-166;

  2. Wang, R I

    1. Enhanced naloxone distribution to the brain by morphine pretreatment in mice.
      D G Lange, J M Fujimoto, S Roerig and R I Wang
      Drug Metabolism and Disposition March 1977, 5 (2) 167-173;

  3. Watkins, W D

    1. Metabolism of pyrazole. Structure elucidation of urinary metabolites.
      K L Clay, W D Watkins and R C Murphy
      Drug Metabolism and Disposition March 1977, 5 (2) 149-156;

  4. Wilkinson, G R

    1. Disposition of carbamazepine and its 10,11-epoxide metabolite in the isolated perfused rat liver.
      A Rane, D G Shand and G R Wilkinson
      Drug Metabolism and Disposition March 1977, 5 (2) 179-184;

  5. Willis, S

    1. The metabolism and toxicity of halogenated carbanilides. Biliary metabolites of 3,4,4'-trichlorocarbanilide and 3-trifluoromethyl-4,4'-dichlorocarbanilide in the rat.
      A R Jeffcoat, R W Handy, M T Francis, S Willis, M E Wall, C G Birch and R A Hiles
      Drug Metabolism and Disposition March 1977, 5 (2) 157-166;

Y

  1. Yoshihara, S

    1. Comparison of the metabolism of parathion by a rat liver reconstituted mixed-function oxidase enzyme system and by a system containing cumene hydroperoxide and purified rat liver cytochrome P-450.
      S Yoshihara and R A Neal
      Drug Metabolism and Disposition March 1977, 5 (2) 191-197;

Z

  1. Zacchei, A G

    1. Urinary metabolites of amitriptyline in the dog.
      H B Hucker, A J Balletto, J Demetriades, B H Arison and A G Zacchei
      Drug Metabolism and Disposition March 1977, 5 (2) 132-142;

  2. Zak, S B

    1. Plasma levels of real and "apparent" hydralazine in man and rat.
      S B Zak, G Lukas and T G Gilleran
      Drug Metabolism and Disposition March 1977, 5 (2) 116-121;
Back to top

In this issue

Advertisement